Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Faculty of Medicine, McGill University, Gatineau, Quebec, Canada.
J Thorac Cardiovasc Surg. 2024 Oct;168(4):1080-1088.e2. doi: 10.1016/j.jtcvs.2023.07.047. Epub 2023 Aug 6.
Sternotomy has been the gold standard incision for surgical revascularization but may be associated with chronic pain and sternal malunion. Minimally invasive coronary artery bypass grafting allows for complete surgical revascularization through a small thoracotomy in selected patients. There is a paucity of long-term data, particularly functional outcomes, for patients who underwent minimally invasive coronary artery bypass grafting.
Patients (N = 566) who underwent minimally invasive coronary artery bypass grafting at a single institution over a 17-year period were prospectively followed. The primary outcome was survival. At late follow-up, patients were contacted for a questionnaire on functional outcomes. Multivariable Cox proportional hazard model identified correlates of the primary outcome.
Clinical follow-up was complete for 100% of patients (mean 7.0 ± 4.4 years); a follow-up questionnaire was also completed for 83.9% (N = 427) of live patients. Fifty percent of patients (N = 283) had undergone multivessel grafting. At 12 years, survival for the entire cohort was 82.2% ± 2.6%. On late follow-up questionnaire, 12 patients (2.8%) had greater than Canadian Cardiovascular Score Class II angina and 19 patients (4.5%) had greater than New York Heart Association Class II symptoms. More than 98% of patients did not have pain related to the incision site. Cox proportional hazards analysis identified older age, peripheral vascular disease, prior myocardial infarction, left ventricular dysfunction, cancer in the past 5 years, intraoperative transfusion, and hybrid revascularization as correlates of mortality during follow-up.
Minimally invasive coronary artery bypass grafting is a safe and durable alternative to sternotomy coronary artery bypass grafting in selected patients, with excellent short- and long-term outcomes, including for multivessel coronary disease. At long-term follow-up, the proportion of patients with significant symptoms and incisional pain was low.
胸骨切开术一直是外科血运重建的金标准,但可能与慢性疼痛和胸骨愈合不良有关。微创冠状动脉旁路移植术可通过在选定的患者中进行小开胸手术来实现完全的外科血运重建。对于接受微创冠状动脉旁路移植术的患者,长期数据(尤其是功能结果)非常有限。
在一家机构进行微创冠状动脉旁路移植术的患者(N=566)在 17 年的时间内进行了前瞻性随访。主要结果是生存。在晚期随访时,联系患者进行了有关功能结果的问卷调查。多变量 Cox 比例风险模型确定了主要结果的相关性。
100%的患者(平均 7.0±4.4 年)完成了临床随访;83.9%(N=427)的存活患者也完成了随访问卷调查。50%的患者(N=283)进行了多血管搭桥。在 12 年时,整个队列的生存率为 82.2%±2.6%。在晚期随访问卷调查中,12 名患者(2.8%)有大于加拿大心血管评分 II 级心绞痛,19 名患者(4.5%)有大于纽约心脏协会 II 级症状。超过 98%的患者没有与切口部位相关的疼痛。Cox 比例风险分析确定年龄较大、外周血管疾病、既往心肌梗死、左心室功能障碍、过去 5 年内的癌症、术中输血和杂交血运重建是随访期间死亡的相关因素。
在选定的患者中,微创冠状动脉旁路移植术是胸骨切开术冠状动脉旁路移植术的一种安全且持久的替代方法,具有出色的短期和长期结果,包括多血管冠状动脉疾病。在长期随访中,有明显症状和切口疼痛的患者比例较低。